1 January 2023 in Case Reports in Pediatrics
Intussusception is the invagination of a proximal bowel segment into a distal segment causing bowel obstruction, especially in children. In some cases, it can be caused by a pathological lead point, such as Burkitt lymphoma. Burkitt lymphoma has several patterns of clinical presentations, such as jaw or facial bone tumor in the endemic form, in contrast to an abdominal presentation most often with massive disease and ascites. We describe a case of a 4‐year‐old male who presented bowel obstruction. Using X‐ray and ultrasound findings, ileocecal intussusception was then diagnosed. Resection and anastomosis was performed after multiple trials of failed hydrostatic reduction. On the pathology report of the resected segment, Burkitt lymphoma was found to be the cause and chemotherapy was initiated. The patient is doing well and is following up every 6 months for 2 years. A pathological lead point, especially Burkitt lymphoma, should be suspected in patients with failed conservative treatment, and prompt diagnosis of the pathology should be performed to prevent further sequela of the disease.
23 August 2024 in JACC: Advances
15 October 2025 in JACC: Cardiovascular Interventions
1 October 2025 in JACC: Case Reports
Immune checkpoint inhibitors (ICIs) are increasingly used in cancer therapy, but they may cause immune-related adverse events, including myocarditis, a rare but potentially fatal complication. A 74-year-old man with lung adenocarcinoma treated with durvalumab presented with acute-on-chronic hypoxemic respiratory failure and hypotension. He was recently diagnosed with ICI pneumonitis and was taking corticosteroids. Evaluation revealed elevated troponins, new T-wave inversions, and reduced left ventricular ejection fraction. Coronary angiography showed no obstructive disease. Cardiac magnetic resonance revealed diffuse myocardial edema with nonischemic late gadolinium enhancement. Endomyocardial biopsy confirmed lymphohistiocytic infiltrates consistent with ICI myocarditis. ICI-associated myocarditis can mimic acute coronary syndrome or stress cardiomyopathy. Cardiac magnetic resonance and biopsy are essential for accurate diagnosis. Early recognition and initiation of high-dose corticosteroids are critical for improved outcomes. ICI myocarditis should be considered in patients with prior ICI exposure and new cardiomyopathy. Multimodal imaging and biopsy are key to timely diagnosis and management.
5 August 2025 in JACC: Cardiovascular Imaging
27 August 2026 in European Heart Journal - Case Reports
Background: Cardiac amyloidosis (CA) is an infiltrative cardiomyopathy caused by extracellular deposition of misfolded amyloid fibrils within the myocardium, resulting in progressive ventricular wall thickening and heart failure. Transthyretin (ATTR) and immunoglobulin light-chain (AL) amyloidosis account for ∼95% of cases. Despite advances in diagnostic imaging and laboratory testing, CA remains underrecognized, often leading to misdiagnosis or delayed diagnosis. Timely and accurate diagnosis, including amyloid subtyping, is critical to guide appropriate therapy and improve clinical outcomes, as prognosis and management vary substantially among amyloid subtypes. Case summary: We present a three-case series illustrating distinct diagnostic and clinical challenges in CA, including a false-positive diagnosis of ATTR cardiomyopathy (ATTR-CM) based on planar technetium-99m pyrophosphate (PYP) scintigraphy that was subsequently ruled out by single-photon emission computed tomography (SPECT) imaging and further evaluation, a delayed diagnosis of AL amyloidosis in a patient with progressive heart failure initially attributed to non-ischaemic cardiomyopathy, and recurrent left atrial appendage thrombus despite therapeutic anticoagulation in a patient with AL amyloidosis. Discussion: These three cases demonstrate the broad spectrum of diagnostic and clinical challenges encountered in CA. The first case underscores the importance of SPECT imaging in differentiating true myocardial radiotracer uptake from blood pool activity, a common source of false-positive planar PYP studies. The second emphasizes the critical role of comprehensive monoclonal protein screening in patients with suspected amyloidosis as delayed diagnosis of AL amyloidosis may adversely affect outcomes. The third illustrates the heightened thromboembolic risk associated with CA, even in the setting of therapeutic anticoagulation, and supports consideration of transoesophageal echocardiography before cardioversion in this high-risk population.